Hunan Jiudian Pharmaceutical Co., Ltd. (SHE:300705)

Market Cap	5.99B -27.2%
Revenue (ttm)	3.01B -0.8%
Net Income	403.78M -21.2%
EPS	0.81 -21.9%
Shares Out	494.11M
PE Ratio	15.03
Forward PE	8.24
Dividend	0.40 (3.31%)
Ex-Dividend Date	May 26, 2025

Volume	5,357,884
Average Volume	5,134,444
Open	12.30
Previous Close	12.12
Day's Range	11.68 - 12.30
52-Week Range	11.69 - 20.66
Beta	0.02
RSI	26.00
Earnings Date	Apr 25, 2026

About SHE:300705

Hunan Jiudian Pharmaceutical Co., Ltd. researches, develops, produces, and sells pharmaceutical products in China and internationally. Its products portfolio includes Pantoprazole Sodium Enteric-coated, Ferrous Succinate, Rosuvastatin Calcium, Ebastine, and Rabeprazole Sodium Enteric-coated Tablets; and Acetylcysteine Granules, Potassium Sodium Hydrogen Citrate Granules, Loxoprofen Sodium Gel Patch, and Ketoprofen gel patch. The company also offers drugs for analgesic, cardio-cerebrovascular, anti-infection, digestive and urinary system, and br...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2001
• Employees: 2,298
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300705

Financial Performance

In 2025, SHE:300705's revenue was 3.11 billion, an increase of 6.15% compared to the previous year's 2.93 billion. Earnings were 472.82 million, a decrease of -7.72%.